Published in Tidsskr Nor Laegeforen on January 10, 1991
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis (1989) 3.66
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost (2007) 3.66
Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med (1989) 2.68
Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ (1999) 2.44
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med (2001) 2.37
The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey. Scand J Rheumatol (1997) 2.13
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut (1997) 2.04
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res (2010) 1.93
Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax (2007) 1.89
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis (2007) 1.87
Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) (1986) 1.83
Efficiency and costs of medical exercise therapy, conventional physiotherapy, and self-exercise in patients with chronic low back pain. A pragmatic, randomized, single-blinded, controlled trial with 1-year follow-up. Spine (Phila Pa 1976) (1998) 1.79
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost (2005) 1.70
[Clinical diagnosis of deep venous thrombosis after hip replacement surgery]. Tidsskr Nor Laegeforen (1997) 1.67
Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis (2004) 1.58
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. J Thromb Haemost (2003) 1.57
Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br (2006) 1.56
Validity of physical activity monitors in adults participating in free-living activities. Br J Sports Med (2008) 1.52
Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients [see comment]. Br Homeopath J (2000) 1.45
Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis (1989) 1.44
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost (2006) 1.44
Untoward effect of diazepam. N Engl J Med (1967) 1.41
A method for determining the size of internal pilot studies. Stat Med (1996) 1.40
Can childhood asthma be predicted at birth? Clin Exp Allergy (2010) 1.40
Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol (2002) 1.39
Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart (2005) 1.38
Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest (1992) 1.35
Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med (1996) 1.33
Systemic meningococcal disease: a model infection to study acute endotoxinemia in man. Prog Clin Biol Res (1988) 1.30
Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur Respir J (1999) 1.28
Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register. Scand J Rheumatol (2006) 1.26
Performance of health status measures with a pen based personal digital assistant. Ann Rheum Dis (2005) 1.25
Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res (2001) 1.23
Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis (2007) 1.18
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. J Thromb Haemost (2004) 1.17
Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioning. Ann Rheum Dis (2005) 1.17
Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis (1992) 1.16
Asthma drug adherence in a long term clinical trial. Arch Dis Child (2000) 1.16
Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994-2004. Ann Rheum Dis (2008) 1.14
Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid. Antimicrob Agents Chemother (1981) 1.08
Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res (1985) 1.05
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran. Thromb Res (2008) 1.05
Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res (1990) 1.05
Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect (2005) 1.04
Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables. Ann Rheum Dis (2004) 1.04
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost (2007) 1.00
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med (2001) 1.00
The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study. Ann Rheum Dis (2007) 1.00
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis (1995) 0.99
Fish oil and plasma fibrinogen. BMJ (1988) 0.98
The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res (1989) 0.98
Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis (2010) 0.98
Isolation and characterization of the cytosolic and chloroplastic 3-phosphoglycerate kinase from spinach leaves. Plant Physiol (1990) 0.98
The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J Infect Dis (1996) 0.98
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res (1995) 0.97
Elevated VIP and endotoxin plasma levels in human gram-negative septic shock. Regul Pept (1989) 0.97
Orthopaedic thromboprophylaxis: limitations of current guidelines. J Bone Joint Surg Br (2008) 0.96
Total protein in common duct bile measured by acetonitrile precipitation and a micro bicinchoninic acid (BCA) method. Scand J Clin Lab Invest (1993) 0.95
Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol (2004) 0.95
Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results. Scand J Gastroenterol (1998) 0.95
LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein. Cytokine (1994) 0.94
Identifying problematic severe asthma in the individual child--does lung function matter? Acta Paediatr (2009) 0.94
Pharmacokinetic studies of antibacterial agents using the suction blister method. Scand J Infect Dis Suppl (1990) 0.94
Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide. J Endotoxin Res (2000) 0.94
Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Ophthalmol Vis Sci (1985) 0.93
Macrophage tropism: fact or fiction? J Leukoc Biol (1997) 0.93
Thromboembolism--an academic concern or a clinical reality? Acta Orthop Scand (1999) 0.92
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res (1993) 0.92
Axillary brachial plexus block with ropivacaine 7.5 mg/ml. A comparative study with bupivacaine 5 mg/ml. Acta Anaesthesiol Scand (1999) 0.92
Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone (2006) 0.92
Different binding of 125I-LPS to plasma proteins from persons with high or low HDL. Scand J Clin Lab Invest (1996) 0.92
Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis. Br J Cancer (2013) 0.91
No difference in mortality between cemented and uncemented hemiprosthesis for elderly patients with cervical hip fracture. A prospective randomized study on 334 patients over 75 years. Arch Orthop Trauma Surg (2013) 0.91
DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet (1989) 0.91
Significance of lipoproteins in serum binding variations of amitriptyline, nortriptyline, and quinidine. Clin Pharmacol Ther (1982) 0.91
Phenotypic and genotypic characterization of Vibrio viscosus sp. nov. and Vibrio wodanis sp. nov. isolated from Atlantic salmon (Salmo salar) with 'winter ulcer'. Int J Syst Evol Microbiol (2000) 0.91
The pipecolate-incorporating enzyme for the biosynthesis of the immunosuppressant rapamycin--nucleotide sequence analysis, disruption and heterologous expression of rapP from Streptomyces hygroscopicus. Eur J Biochem (1997) 0.91
Clinical assessment of pharyngitis in general practice. Scand J Prim Health Care (1988) 0.91
Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood. Thromb Haemost (1996) 0.91
Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb Pathog (1992) 0.91
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91
Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int (1992) 0.90
The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis. J Rheumatol (1991) 0.89
LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine (1996) 0.89
Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg (1996) 0.89
Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest (2000) 0.88
Reduced basal salivary cortisol in children with asthma and allergic rhinitis. Acta Paediatr (2010) 0.88
Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes. Thromb Haemost (1996) 0.88
Drug binding in sera deficient in lipoproteins, albumin or orosomucoid. Br J Clin Pharmacol (1983) 0.88
Adalimumab and methotrexate is more effective than adalimumab alone in patients with established rheumatoid arthritis: results from a 6-month longitudinal, observational, multicentre study. Ann Rheum Dis (2006) 0.88
Studies on soluble fibrin in plasma. I. N-terminal analysis of a modified fraction I (Cohn) from normal and thrombin-incubated plasma. Scand J Clin Lab Invest (1971) 0.87
Thrombin generation during collection and storage of blood. Vox Sang (1986) 0.87
Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide. Br J Clin Pharmacol (1984) 0.87
Fibrinemia in medical patients screened by the ethanol test. Acta Med Scand (1971) 0.86
Bacteremia and compartmentalization of LPS in meningococcal disease. Prog Clin Biol Res (1995) 0.86
Orthopaedic surgery in 255 patients with inflammatory arthropathies: longitudinal effects on pain, physical function and health-related quality of life. Ann Rheum Dis (2008) 0.86
Lung function measurements in awake compared to sleeping newborn infants. Pediatr Pulmonol (1992) 0.86
Derivation and validation of a simple risk score for predicting 1-year mortality in stroke. J Neurol (2007) 0.85